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Abstract
Ocular involvement in Zika virus (ZIKV) infection can be present both in adults 
and infants as acquired and congenital diseases respectively. Through experimental 
studies, there has been clarified important mechanisms of ocular pathogenesis that 
allow the establishment of potential objectives for antiviral drugs development. The 
spread of the virus at the ocular level could be hematogenous or axonal, however 
the hematogenous route through the choroid is suggested as the most important 
initial mechanism for infection. Ocular manifestations vary according to the age 
of presentation, being mild and self-limited in adults and potentially devastating 
in children, related to congenital Zika syndrome (CZS). Ocular diagnosis is made 
based in clinical features and contact/travel history to countries of epidemiologi-
cal importance; fundoscopy, optical coherence tomography, fluoresceinic/green 
indocianine angiography, cultures, serological and molecular tests are useful diag-
nostic tools. Ocular management is focused according to the clinical context of each 
patient. Prevention is carried out in a comprehensive manner and further research 
is directed to vaccine development and specific antiviral treatment. Proper atten-
tion requires a multidisciplinary team in order to reach complete visual evaluation 
and early rehabilitation.
Keywords: Zika virus, congenital Zika syndrome, uveitis, optic nerve hypoplasia, 
conjunctivitis
1. Introduction
Zika virus (ZIKV) is a mosquito-borne viral disease caused by a flavivirus from the 
Flaviviridae family and transmitted by species belonging mainly to genus Aedes, dis-
covered in 1947 in Uganda in infected rhesus monkeys [1, 2] with the first human cases 
reported in Africa and Asia [3]. Latin America and the Caribbean started to be affected 
with outbreaks, the first one reported in 2015 in Brazil [4]. Systemic symptoms include 
fever, maculo-papular rash, headache, arthralgia and conjunctivitis [2, 5].
Ocular involvement of ZIKV is not an uncommon manifestation in a patient 
with Zika virus infection. There are two main situations in which ocular pathology 
can occur: The first one is the manifestation of the virus in an adult patient, includ-
ing the non-purulent conjunctivitis and more rarely ocular inflammation, especially 
in the anterior segment [6, 7]. Non-purulent conjunctivitis occurs between 55 and 
63% of patients, as reported in outbreaks from Yap Islands and French Polineise, 
however according to other studies, conjunctivitis only occurs between 10 and 25% 
of patients infected with ZIKV [8–10].
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The second way implies ocular abnormalities of congenital etiology, that belongs 
to the congenital Zika syndrome (CZS) [11]. The most prevalent congenital disorder 
is brain calcifications (42.6; 95%CI, 30.8–54.4), meanwhile the prevalence of ocular 
disorders was less frequent (4.2; 95% CI, 1.0–7.5) [10]. The overall presentation rate of 
ocular manifestations in infants with CZS is 21.4–55% [11, 12]. Infection due to ZIKV 
in the first trimester of pregnancy can trigger the presentation of CZS in 1–13% of the 
cases with ocular manifestations in patients present up to 70% of cases [13].
First report in literature about ocular manifestation in CZS was published in 2016 
with three cases of children with mothers exposed to the virus during gestational 
age, leading to macular chorioretinal atrophy in all cases [14]. A second report of 
ocular anomalies related to CZS was done in a 10 case-series, informing horizontal 
nystagmus in 10% of cases, exophoria in 40% of cases, esophoria in 20% of cases, 
macular alterations like gross pigment mottling and/or chorioretinal atrophy and 
optic nerve anomalies like hypoplasia with double-ring sign, pallor, and/or increased 
cup-to-disk ratio in 75 and 45% of evaluated eyes respectively [15]. An interesting 
fact about these ocular anomalies is that it is not required the presence of microceph-
aly to get an ocular involvement, like was reported by Ventura et al. in an infant with 
cerebral calcifications and an unilateral chorioretinal scar in macular region [16] .
In the same year, it was reported a case series including 29 patients with micro-
cephaly due to CZS, in which 36.5% had some degree of ocular involvement: Lens 
subluxation, bilateral iris coloboma, optic nerve abnormalities and chorioretinal 
atrophy in 5.9, 11.8, 47.1 and 64.7% of cases respectively [17]. Afterwards, in 2017, 
in a bigger sample (70 children with microcephaly),36% were positive to ophthal-
mological findings like macular and optic nerve anomalies (26% of ocular cases), 
strabismus/nystagmus (10% of ocular cases) and suboptimal visual acuity (100% 
of ocular cases) [18]. Zin et al. reported a cohort of 112 children with 21.4% of cases 
with positive ocular findings: 79.2% of cases with optic nerve abnormalities, 58.3% 
with retinal involvement, 25% with nystagmus, 4.2% with microphthalmia [19].
In Colombia and near countries like Venezuela, exists studies reporting ocular 
findings [20], like a study with 43 microcephalic children, of which 12% presented 
optic nerve hypoplasia, 63% macular pigment mottling, 7% lacunar maculopathy 
and 12% developed congenital glaucoma [21]. Alvarado-Socarras et al. reported a 
case series of children born from women infected with ZIKV, where two children 
had intraretinal hemorrhages, hyper/hypopigmented lesions. The increased risk for 
ocular ZIKV in these cases where derived from the presence of microcephaly and 
the infection during pregnancy [22].
In an attempt to assess the risk factors associated to ocular manifestations, Ventura 
et al. conducted a cross-sectional study including 40 microcephalic children, 60% of 
them with ZIKV positive infection. There was a statistically significant relationship 
of ocular manifestations to children with smaller cephalic diameter at birth (95%CI, 
−2.56 to −0.51; P = 0.004) and infants whose mothers reported symptoms during the 
first trimester (95%CI, 0.02–0.67; P = 0.04) [23]. It is relevant to mention that not 
only ocular structural changes are manifest in children with CZS, but also functional 
abnormalities like ocular motor disorders, visual fields defects (45.1% of cases), 
low contrast sensitivity (81.3% of cases), hypoaccomodation and refractive errors. 
Prevalence rate of severe visual impairment without structural changes is present 
in 84.6% of cases, related to cortical/cerebral involvement [24]. According to Baran 
et al., visual acuity losses occur in children with gestational infection, with a slowing 
of visual development even in the absence of microcephaly [25].
It is not necessary the presence of microcephaly in children or ZIKV systemic 
symptoms in pregnant women to manifest ocular abnormalities. Ocular involve-
ment caused by Zika virus should be included in differential diagnosis, especially 
in endemic areas, of any patient presenting ocular manifestations and a history of 
3The Eye and the Zika Virus
DOI: http://dx.doi.org/10.5772/intechopen.89847
fever. This chapter describes the most important aspects of the ocular compromise 
caused by ZIKV, items that the clinicians should consider when approaching a 
patient with a suspected ocular involvement by the mentioned virus.
2. Ocular pathogenesis
ZIKV, similar to other flaviviruses, has an icosahedral envelope with positive 
single-stranded RNA as a genetic material that encodes a polyprotein processed 
by viral and cellular proteases into three structural proteins: capsid proteins, 
membrane and envelope that form the viral particle and mediate the binding of the 
virus, allowing entry and encapsidation. Seven non-structural proteins (NS) (NS1, 
NS2A, NS2B, NS3, NS4A, NS4B and NS5), play a role for polyproteins processing 
and the induction of an innate antiviral response in the host. The main surface 
glycoprotein involved in the binding of the host cell and the fusion of the viral 
membrane is the envelope protein, which allows the fixation and fusion of the viral 
particle to the host cell and is a useful tool in the diagnosis [26]. Viral reproduction 
is achieved through non-structural proteins (NS1–NS5), which serve as self-divid-
ing peptidases, together with viral RNA-dependent RNA polymerase [27].
Through the endocytosis process, the virion enters the cytoplasm of the cells [28]. 
Non-structural proteins bind to the endoplasmic reticulum, where viral replication 
of RNA is performed using cell structure and dynamics and released by cellular 
apoptosis. Subsequently, it takes the viral phase that occurs between 3 and 5 days 
after the first symptoms, then hematogenous spread to organs and tissues occurs. It 
is believed that the virus could have neuronal (pantropic) and other organ tropism, 
because viral RNA has been found in the brain, as well as in the liver, kidney, heart 
and spleen [29]. There are also other forms of transmission called non-vector, such as 
vertical transmission [30, 31], sexual transmission and blood transfusion [32, 33].
The pathophysiology of the ocular findings is not known in detail so far. It has 
been studied in animal models and deceased fetuses that have tried to demonstrate 
the great retinal compromise that includes macular abnormalities such as pigment 
spots and chorioretinal atrophy, loss of retinal pigment epithelium, perivascular 
choroidal inflammatory infiltrate and optic nerve abnormalities such as hypoplasia, 
paleness and increased cup-disc ratio. Other publications describe additional find-
ings, such as iris coloboma, lens subluxation, cataracts, glaucoma, and microph-
thalmia [15, 34, 35]. At the ocular level, Zika virus infection can affect any part 
of the uveal tract (iris, ciliary body, retina and choroid), since most clinical cases 
have defects in the posterior segment [14, 15]. The hematoretinal barrier formed 
by vascular endothelial cells of the inner retina and external RPE (Retinal Pigment 
Epithelium) cells constitutes the first protective barrier that is responsible to con-
trol the entry of innate immune cells and pathogens into the posterior eye segment 
[36, 37]. The type I interferon (IFN) response is an important defense mechanism 
against most flaviviruses. A129 mice, which are deficient in IFN α and β receptors, 
have been commonly used as an animal model to study ZIKV infection [38, 39].
By detection of RNA nucleic acids in animal models, it has been suggested 
that the ocular infection can spread hematogenously to the brain and the eye 
simultaneously, although it is not possible to rule out the transfer through the optic 
nerve, in which there has been shown that houses the higher concentration of viral 
antigen. Therefore, the spread of the virus at the ocular level could be hematog-
enous or axonal, as studies show, however the viral peak during viremia suggests 
the hematogenous route through the choroid choroid as a more important initial 
mechanism. After day 3, the progressive increase in viral RNA levels in the eye is 
markedly different from that of peripheral blood [40]. In a hypothetical study using 
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human target cells, it was shown that the pathophysiology of ocular ZIKV begins 
when it spreads throughout the retinal bed through the retinal arteries affecting 
the endothelial cells and the retinal pericytes of the internal hematoretinal barrier 
and then compromises the choroid to infect the external hematoretinal barrier by 
compromising the RPE cells and allowing the amplification and spread of the virus 
in the retinal bed. It was found that retinal endothelial cells are highly permissive 
for ZIKV and showed important cytopathic effects. It was shown that Müller cells 
are not permissive for ZIKV infection and photoreceptor cells appear to be even less 
so. The highest levels of ZIKV transcription were observed in retinal pericytes [41].
It has been documented that the entry and binding of several viruses at the 
cellular level is facilitated by the TAM (tyrosine kinase) receptors as well as the TLR 
[36] (toll like receptor) that play an important role in the organization of  
the innate responses of the retina in the microbial infection. Among them, AXL 
(TAM type receptor) was identified as the main receptor involved and together 
with the TLR3 (toll like receptor) that is involved in the viral infection, they allow 
the binding of the virus and its respective anchorage to the cellular guest machinery. 
These findings suggest that ZIKV can use AXL as an input receptor to gain access to 
hematoretinal barrier cells and therefore cause retinal pathology. Host cells employ 
intracellular pathogen recognition receptors, such as TLR and RIG-I-like receptors, 
for the recognition and initiation of innate immune responses, in particular with 
the generation of the interferon pathway (IFN type I). ISG15 induced by type I IFN 
is generally considered an antiviral gene that plays a protective role in the retina 
against ZIKV infection. Although, ISG15 has been shown to influence viral replica-
tion both positively and negatively. The expression of several IFN-induced antiviral 
genes has also been demonstrated, including OAS2 and MX1 [40–42].
In animal models it has been seen that by day 9 of the infection process, there is 
activation of local glial cells and the start of cell recruitment given a subtle increase 
in the gene expression of MHC, B2m and STAT1. In addition, there is an increase in 
TNFα, granzyme, perforin and IFNγ without evidence of CD3 or CD8 T markers, 
suggesting that possibly NK cells reach the eye in the early stages of the disease  
[40, 42]. A few days later (days 12–16), when mice develop clinical signs of 
encephalitis, chemokine expression in the eyes peaks. The analysis of the profile of 
cytokines and adhesion molecules reveals a marginal increase in the levels of β2-m, 
GMCSF and MCP1 and a moderate increase in the expression of ICAM-1, IL-6 and 
VCAM-1; and higher levels of RANTES expression (Regulators after activation, 
normal T cells expressed and presumably secreted) are evidenced in ZIKV infected 
cells. This elevation recruits inflammatory cells in the retinal microenvironment 
and produces chronicity [41]. Recent studies in mouse models suggest that ZIKV is 
located in the iridocorneal angle and in the trabecular meshwork where through the 
already mentioned mechanisms, they induce cell death at the level of the trabecular 
meshwork, leading to induction of inflammatory response that causes trabeculitis 
and could be one of the potential mechanisms for the IOP increase and glaucoma-
tous pathology [43]. Furthermore, once the infection is located at the ocular level, 
panuveitis can be generated in the presence of ZIKV in the layers of the cornea, cho-
roid, bipolar and ganglion cells of the retina and optic nerve and therefore the viral 
RNA can be secreted from tear glands or detached from the cornea to the tears [44].
Several studies have been conducted in animal models to try to address the 
pathophysiological mechanism involved in the development of eye disorders. Van 
den Pol et al. studied an animal model in infected newborn mice, which exhibit a 
brain development process similar to the human brain fetus in the second trimester. 
They mainly analyzed the brain and the visual pathway, identifying the damage 
caused by ZIKV in the entire visual system, including the retina, the optic chiasma, 
the suprachiasmatic nucleus, the lateral geniculate nucleus and/or the superior 
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colliculus. The theory postulated that ZIKV can be transported axonally, which 
improves the spread of the virus within the brain, with a fundamental role of glial 
cells to understand the mechanism behind neurological and ocular findings [45].
Singh et al. also conducted an animal model study that only analyzed the 
pathophysiology of retinal findings demonstrating that retinal cells, including those 
of the RPE, are permissible for ZIKV replication and express receptors for them. In 
addition, they are susceptible to ZIKV-induced cell death, leading to retinal lesions 
because of the virus ability to break the integrity of the hematoretinal barrier. They 
suggested that ISG15 (Interferon-stimulated gene 15) and its antiviral activity, plays 
a role in the innate defense of the retina against ZIKV infection [46].
In a subsequent study with a murine model, Zhao et al. showed that ZIKV can 
infect the retina in immunodeficient and immunocompetent mice and affect mul-
tiple retinal layers. ZIKV preferentially infects RPE and Müller cells, which are key 
support cells for neuronal survival, function and repair of retinal lesions. Müller 
cell ablation causes neurological and vascular pathological effects that resemble 
the ocular characteristics of congenital eye disease due to ZIKV. Müller cells show a 
decreased neurotrophic function with a post-infection up-regulation of cytokines 
Figure 1. 
Pathogenic infection process by ZIKV to the retinal pigment epithelium.
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levels [47]. In a more recent study, Aleman et al. [48]. provided the first evidence 
in-vivo in humans that shows central retinal degeneration with severe loss of gan-
glion cells and a borderline thinning of nerve fibers, as well as a less prominent loss 
of photoreceptors. The findings provide the first evidence to date, in humans, that 
ganglion cells -and perhaps surrounding glia cells- are the primary cellular targets 
in the retina of patients with ZIKV infection, which is consistent with the murine 
disease model that suggest a depletion of this neuronal population in the uterus as 
a result of the infection [44]. Figure 1, resumes some of the pathogenic theories 
involving the ZIKV and its infection to some of the retinal cells.
3. Ophthalmologic manifestations
3.1 Ocular findings in infants with congenital Zika virus infection
The most important findings of ophthalmologic abnormalities associated with 
Zika virus infection are reported in infants with microcephaly due to Zika congeni-
tal infection, leading to a broad spectrum of ophthalmological manifestations. It is 
proposed that the ocular findings could be a result of the direct effect of Zika virus 
itself and not only a consequence of microcephaly, because of the known deleteri-
ous effects of the virus on the central nervous system [14, 49–51]. The increased 
neurotropism of the virus explains why the retina and optic nerve are the main 
structures affected in infants with congenital Zika virus syndrome. It has been pro-
posed that the typical optic nerve hypoplasia is more related to microcephaly, and 
the retinal anomalies specially found in the neurosensory retina are associated to an 
inflammatory reaction due to the virus toxin. The majority of findings are bilateral 
[23, 52]. There is no report of uveitis in congenital cases [53].
Zika exposure without infection during gestation does not seem to affect ocular 
status, visual acuity or visual development. When the Zika virus is vertically 
transmitted to the fetus and the subsequent infection is confirmed, the infant may 
show ophthalmologic and visual function damage. There has been described retinal 
abnormalities in children with microcephaly attributed to Zika virus infection 
during pregnancy, found in 60–85% of the affected patients with ocular findings, 
including optic nerve abnormalities and macular alterations [23, 51]. It is hypoth-
esized that the most sever ophthalmic manifestations occur when the infection 
takes place in the first or second trimester of pregnancy, because of the Zika’s 
tropism related to the neural precursors, which are available in the early phases of 
cerebral differentiation [10, 23, 54, 55]. It has been found that retinal findings are 
more prevalent when the infection takes place in the first trimester and the related 
viral load may be relevant to the final process that results affecting the macula. In 
the other hand, the optic nerve could be affected in all trimesters [5].
3.1.1 Optic nerve findings and macular abnormalities
Optic nerve hypoplasia is one of the most important findings in infants with 
congenital Zika virus infection [51]. This condition can be identified with the double 
ring sign as a manifestation of a small and undeveloped optic nerve [23, 52, 56, 
57] (Figure 1). Other typical signs of insult to the optic nerve include pallor and 
increased cup-to-disk ratio [13, 15, 56, 57] (Figure 2). The most frequent macular 
findings associated with congenital Zika virus infection include gross pigment 
mottling, foveal reflex loss and chorioretinal atrophy, which differs from toxo-
plasmosis scars because of the absence of intraocular inflammatory signs and the 
presentation of a typical dark pigmentation rim around the atrophic area [15, 18, 58]. 
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The circumscribed macular atrophy observed in the affected children seems to be 
pathognomonic to congenital Zika syndrome [5, 6, 50]. The macular atrophy caused 
by Zika virus infection is mostly associated with involvement of the outer retinal lay-
ers and choriocapillaris (Figure 3). Inner retinal vascular abnormalities could also be 
present and associated with post-viral neurological sequelae of Zika virus infection, 
in addition to the well-known outer retinal effects of the infectious disease [59].
3.1.2 Anterior segment findings
Anterior ocular findings related to Zika virus infection include iris coloboma, 
cataracts, lens subluxation, intraocular calcifications and microphthalmia even in 
the absence of microcephaly [34, 60]. However, it is known that the incidence of 
structural eye alterations, visual acuity loss and fundus abnormalities are signifi-
cantly higher when the infected child exhibits concomitant microcephaly [14, 25].
Figure 2. 
Optic disc hypoplasia with double-ring sign associated with hyperpigmented mottling and one sharply 
demarcated chorioretinal atrophy on the macula. Image courtesy from Camila Ventura, MD, PhD. Altino 
Ventura foundation (FAV) - HOPE eye hospital. reproduced with permission.
Figure 3. 
Macular chorioretinal atrophy, hyperpigmented mottling, vascular attenuation and optic disc hypoplasia. 




3.1.3 Ocular motility alterations and vascular findings
Among infants with congenital Zika virus infection, the most commonly 
reported ocular motility disturbances include early-onset strabismus, nystagmus 
and ocular flutter [21, 25, 60]. The vascular findings are mainly subretinal hemor-
rhages and abnormalities in peripheral retinal vasculature, including abnormal 
termination of the retinal vessels, tortuosity and vascular attenuation [21].
3.1.4 Congenital glaucoma
This condition is rare (2.6%) but can occur in infants presenting with CZS 
and microcephaly. The related findings include and enlarged and cloudy cornea, 
buphthalmos, photophobia and excessive tearing [11, 57, 61].
The important increase in the prevalence of microcephaly in newborn infants 
in the Americas, in association with the previously described abnormal and 
vision-threatening ocular findings, should promptly lead to suspect the diagnosis 
of congenital infection due to Zika virus in these epidemic regions, which could 
be confirmed with real-time polymerase chain reaction in the first 5 days of acute 
phase of infection, after ruling out TORCH infections [62]. It is clear that infants 
with microcephaly should be screened for ocular lesions, but it is so important to 
consider that infants without microcephaly may have eye lesions. Then all children 
of the epidemic areas, such as South America, Central America and the Caribbean, 
with potential maternal Zika virus exposure at any time during pregnancy should 
be screened for ocular implication regardless of the presence of central nervous 
system alterations, because ocular findings could be underdiagnosed if micro-
cephaly continues to be the main inclusion criterion in the screening of this group 
of children [16, 19, 63]. In addition, all newborns with mothers infected with Zika 
virus during pregnancy should have an early ophthalmological evaluation including 
the proper posterior pole examination through full dilation of the pupil [17, 64, 65].
3.2 Ocular findings in adults
The most important difference between infants and adults is that in adults there 
could be seen symptoms and signs of an active infectious process with the chance 
of detecting the Zika virus during a viremic period. In adults, only 20% of adults 
are symptomatic, and therefore the majority of adults with an acute Zika virus 
infection are asymptomatic [66]. Instead, in infants the related ocular findings are 
usually scars, as a manifestation of a post-infection process.
Symptomatic patients infected with Zika virus can exhibit a non-purulent con-
junctivitis as a non-specific manifestation in the mild course of the disease [8, 67, 
68]. Hypertensive iridocyclitis secondary to Zika virus infection has been reported 
during the acute phase of the disease, associated with ocular discomfort, redness 
and blurry vision, variable ciliary injection and anterior chamber reaction, miosis 
and elevation of the intraocular pressure. The findings usually ease after the viremia 
decreases and the use of topical treatment with steroids, cycloplegic and ocular 
hypotensive agents [69–71].
Other ocular findings in adults during acute infection include unilateral acute 
maculopathy, which exhibits a grayish annulus and pigment mottling as fundo-
scopic alterations, as well as disruption of the outer retinal and retinal pigment 
epithelium architecture in the central macula on optical coherence tomography 
and early hypofluorescence with irregular late central staining on angiogram, in 
addition to prompt resolution with visual function recovery [72, 73]. Neuroretinitis 
with a macular-star pattern has also been described in literature [74]. There could 
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be found associated placoid or multifocal non-necrotizing chorioretinal lesions, 
especially in immunocompromised patients, that usually evolve with scaring and 
posterior improvement of visual acuity. Then, these chorioretinal lesions may be a 
manifestation of the active phase of infection in patients with viremia [24, 40, 75].
4. Systemic diagnosis
After clinical evaluation in individuals showing clinically compatible symptoms, 
the laboratory diagnosis of acute infection is based on the use of molecular tests for 
direct detection of viral nucleic acids (RNA) in blood and other biological samples 
and serological tests with tests of Enzymatic immunosorption (ELISA) or immuno-
fluorescence assays (IFA) which allow the detection of IgM and IgG antibodies in 
serum. In a specialized manner, virus neutralization assays can also be performed 
to confirm the specificity of the ELISA or IFA tests, as well as cell cultures to isolate 
the virus [8, 76].
During the acute phase of the infection, the diagnosis is based on the detection 
of viral nucleic acid (RNA) by (RT-PCR) polymerase chain reaction of reverse tran-
scription in blood, urine and saliva samples as well as in others biological samples 
such as CSF, amniotic fluid, semen [77], fetoplacental tissue and aqueous humor. 
Furtado et al. reported the case of a patient using aqueous humor to perform 
RT-PCR [70]. Two separate samples should be collected: the first during the acute 
phase and the second in the next 2–3 weeks [78]. If the result is negative, serological 
tests such as IGM should be supplemented, if they are positive, the plaque reduction 
neutralization test (PRNT) is performed as complement to determine whether or 
not there is a recent infection [76]. The conjunctival fluid contains virus for up to 
7 days compared to urine and saliva samples of less than 20 days [79, 80].
4.1 Case confirmation
The Center for Disease Control recommends that an initial clinical evaluation 
should be performed in all infants with evidence of exposure to ZIKV or with sug-
gestive laboratories, regardless of whether they have abnormalities consistent with 
ZIKV infection. There should be also evaluated those infants with abnormal clinical 
or neuroimaging findings, such as intracranial calcifications that were detected 
prenatally or during childbirth, and whose mothers were potentially infected with 
ZIKV during pregnancy [81].
According to the ECDC, a case is defined as confirmed when at least one of the 
following laboratory criteria is present: nucleic acid detection (RNA), antigens in a 
clinical sample; virus isolation in a clinical sample; detection of specific antibodies 
(IGM) in serum samples and confirmation by neutralization test; seroconversion or 
quadruple increase in the titer of specific antibodies against ZIKV in paired serum 
samples. A case is defined as probable if specific IgM antibodies are detected in 
serum. Epidemiological criteria must be taken into account [82]. It is recommended 
to perform funduscopy under pharmacological dilation in those patients with risk 
factors at least once within the first month and repeat at 3 months as a follow-up for 
those patients with confirmed diagnosis.
5. Ophthalmic diagnosis
ZIKV infection can occur with a wide spectrum of ocular findings, the most 
characteristic being the mottled pigment and chorioretinal atrophy that are 
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commonly observed in the posterior pole especially in the macular area. There 
has been reported cases in the literature with manifestations that include con-
junctivitis, uveitis [70], unilateral acute idiopathic maculopathy, chorioretinal 
lesions of acute onset, self-resolution, non-necrotizing multifocal placoids or 
manifestations such as manifestation of active chorioretinitis due to virus [75], 
optic neuropathy and congenital glaucoma [61], retinal vasculopathy [59], and 
hypertensive iridocyclitis [71].
The funduscopy is clinically important as a diagnostic tool and atrophic 
pigmented macular and peri-macular lesions, diffuse RPE damage and chorioreti-
nal atrophy can be observed [14]. There are reports where funduscopy revealed 
pigmented external retinal lesions, retinal vascular abnormalities as tortuosity 
and dilation and atrophy of the optic nerve [11, 83]. In the peripheral retina 
a hypolucid spot can be observed as well as scattered subretinal hemorrhages 
external to the macula.
In fluorescein angiography early blockage and late staining in the retinal pig-
ment epithelium is present. In autoflorescence, multimodal images showed a group 
of hyperautofluorescent lesions, it has also been described that there were focal 
areas of presumed choroiditis visualized as hypercynesic lesions in indocyanine 
green angiography [83].
Furtado et al. reported the case of a patient diagnosed with Zika by molecu-
lar and serological tests as well as positive ZIKV RNA in (RT-PCR) in aqueous 
humor obtained by anterior chamber paracentesis and described bilateral 
conjunctival hyperemia, bilateral non-granulomatous keratic precipitates and 
positive cellularity in the anterior chamber [70]. Parke et al. presented the case 
of a patient in whom alterations in the RPE with a gray ring around the fovea 
were observed and evidence by optical coherence tomography in the external 
retina and with macular area compromise. The above findings were in relation 
to a positive result for molecular testing with PRNT neutralization reduction 
technique of ZIKV [73].
5.1 Optical coherence tomography
For a better understanding of the ocular findings and as a follow-up to the 
characteristics probably related to ZIKV infection at the ocular level, some studies 
that analyzed the retinal tissue have been performed, Ventura et al. for example 
described the related findings by OCT in a series of consecutive cross-sectional 
cases that included 8 infants. The main OCT findings in the affected eyes included 
disruption of the ellipsoid zone and hyperreflectivity underlying the retinal pig-
ment epithelium, thinning of the retina and choroid, and a colobomatous excava-
tion [84].
Oliveira et al. described that the OCT results show a wide range of retinal dam-
age caused by congenital ZIKV infection, and reinforced the findings compatible 
with chorioretinal atrophy [85]. Campos et al. described a case report with similar 
findings that correspond to retina thinning with atrophy of the external retina, 
including the outer nuclear layer and the ellipsoid zone, associated with hyper-
reflectivity of the RPE and increased OCT penetration into deeper layers of the 
choroid and sclera (Figure 4) [86] .
Henry et al. used images of fluorescein-like fundus lesions and indocyanine 
green angiography, autofluorescence and optical coherence tomography associated 
with ZIKV and described acute and multifocal posterior non-necrotizing placoid 
epitheliopathy lesions that could be characteristic of active chorioretinitis due to 
ZIKV [75]. The findings described by OCT suggested that the neurotropism mani-
fested by the ZIKV corresponds to significant necrosis areas of the retinal tissue.
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6. Systemic treatment
There is no specific approved antiviral treatment nor vaccines for the ZIKV 
infection to date. Actual treatment due to this virus is focused in control of 
symptoms (rest, fluid ingestion, antipyretics as paracetamol) [2, 53]. There are 
several compounds been tested in-vitro, each one with different action mechanism 
between each other’s: Inhibition of the replication of the virus at early and late 
phases (For instance the Direct Acting Agents);inhibition of the molecular attach-
ment, endocytosis and fusion mechanisms of the virus leading to block the viral 
entry, like duramycin, suramin and nanchangmycin [87, 88]. Some different mol-
ecules are being studied in animal models such as Z2 synthetic peptide inhibitor and 
the cholesterol-25-hydroxylase, which interfere vertical transmission in pregnant 
mice and cause cholesterol oxidation respectively [89, 90]. Novobioctin, lopinavir-
ritonavir and bromocriptine cause an inhibition of the protease activity (NS2B-NS3 
vial protease protein) [91, 92].
There is a growing interest in developing a vaccine against the ZIKV that could 
be used, especially in pregnant women. Animal models have been implemented, 
like knockout mice with shortcomings in IFN-I or IFN-II receptors, recreating many 
of the characteristics of the infection. The vaccine candidates that are been studied 
are in phase I or II, being the most promising a ZIKV-purified inactivate virus, or 
nucleic acid and adenovirus-based vaccines against the prM and E proteins provid-
ing long term protection in monkeys and mice [93–97].
7. Ocular treatment
There is no existence of guidelines or clinical trials about the treatment of ocular 
manifestation in ZIKV infection. The available data is extracted of case reports 
and case series. It is mandatory to focus the treatment according to the ophthalmic 
Figure 4. 
Spectral domain OCT of a macular lesion in an infant with presumed Zika virus-associated microcephaly, 
demonstrating retinal thinning with atrophy of the outer retina, including the outer nuclear layer and ellipsoid 
zone, associated with retinal pigment epithelium hyper-reflectivity and increased penetration of OCT into 
deeper layers of the choroid and sclera. Taken from Campos AG, Lira RP, Arantes TE. Optical coherence 
tomography of macular atrophy associated with microcephaly and presumed intrauterine Zika virus infection. 




clinical context of each patient. In a patient with ophthalmologic manifestations 
that are presumed to be derived from ZIKV, it is necessary to exclude other causes 
before, then specific treatment is established.
In adults, ocular compromise in acute phases of the ZIKV infection could be 
treated with topical steroids, cycloplegic, and hypotensive topical medication 
according to ocular signs and symptoms present at that moment. Ocular compro-
mise in children require a multidisciplinary approach and a focused treatment 
according to the present ocular conditions [53]. Cases with refractive errors, 
anisometropias, hypoaccomodation, amblyopia, and strabismus requires visual 
development therapies (eyeglasses, patching, ortoptics, and strabismus surgery) 
that are key in visual rehabilitation [12, 98].
Cases of anterior uveitis derived from ZIKV infection, usually are self-limiting 
course, which makes redundant the need of therapy [99]. However, there are cases 
of hypertensive acute anterior uveitis treated with β-Blockers and carbonic anhy-
drase inhibitor eyedrops accompanied or not with topical steroids and cycloplegics 
with normalization after treatment [70, 71, 100]. Kodati et al. reported an adult 
case of posterior uveitis and chorioretinal lesions in an inmunocompetent patient 
treated with loteprednol etabonate 0.5% three times daily, then reaching visual 
acuities of 20/20, with remaining photopsias [69].
Cases of bilateral optic neuritis in adults related to ZIKV were treated with 
intravenous methylprednisolone for 3 days followed by oral prednisolone for 11 addi-
tional days leading to a modest and partial recovery of visual acuity [61, 101]. Ocular 
flutter in a ZIKV post-infection state patient with neurological additional symptoms 
were described with improvement after intravenous immunoglobulin for 5 days [60].
Retinal disease associated to ZIKV, sometimes manifested as perifoveal microaneu-
rysms with no involvement of visual function did not require any additional treatment 
beyond observation [59]. Acute maculopathy with bull’s-eye shape were reported in an 
adult case, with total improvement of visual acuity after 6 weeks without any treat-
ment [73]. There is a study were the pharmacological inhibition of ABCG1, a mem-
brane transporter of cholesterol, resulted in reduced ZIKV infectivity of RPE [42].
Glaucoma in Congenital Zika syndrome is a visual-threatening condition that 
need special attention and early treatment, were the use of hypotensive topical 
medications and surgery like trabeculotomy, trabeculectomy, trabeculotomy plus 
trabeculectomy or goniotomy are the most used strategies [13, 21, 57, 61].
8. Visual prognosis in children with congenital ZIKV infection
The infants affected with congenital Zika virus syndrome may manifest many 
structural ocular findings in addition to the typical ones than involve the posterior 
pole, presenting low contrast sensitivity, visual field defects, hypoaccommodation, 
refractive errors and ocular motor disorders such as strabismus and nystagmus, 
commonly associated to neurological conditions, that finally interfere with the 
development of stereopsis and binocular vision. The sum of all of these findings 
results in severe visual impairment, regardless of the abnormalities of the retina 
and optic nerve [24].
There has been reported that even in the absence of apparent ocular abnormali-
ties, there is a high prevalence of visual impairment between infants with micro-
cephaly due to congenital Zika syndrome, suggesting that cerebral visual impairment, 
as a result of extensive damage to the central nervous system, could be the most 
frequent cause of blindness in affected infants [98, 102, 103]. This condition is known 
as cortical visual impairment, which is a reduction in visual response due to a neuro-
logic issue. Then, the visual prognosis could be committed even in absence of ocular 
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damage because of the severe cerebral malformation and abnormal brain develop-
ment related to Zika infection. The affected infants usually have some vision and then 
they could exhibit improvement of their abilities over time. There could be seen the 
necessity of multidisciplinary teams for early cognitive and visual stimulation of new-
borns affected by congenital Zika virus syndrome, in order to decrease the impact of 
these infants and their families and achieve better quality of life. Further studies with 
long follow-up periods are needed to recognize the impact of the described ocular and 
neurological abnormalities, as well as for a better understanding and description of 
the natural history related to Zika infection and its ocular sequelae [13].
The early recognition, assessment and intervention of children with congenital 
Zika virus syndrome is crucial, especially in those ones that present hypoaccom-
modation and refractive errors, because they could show a significant improvement 
in visual acuity if they receive an early intervention with proper eyeglasses, as part 
of an integral visual stimulation therapy. For achieving significant changes in their 
refractive status it is necessary to guarantee periodical updates over time.
9. Visual prognosis in adults
In general terms, there is a benign visual evolution in adults, because the symp-
toms and signs are associated with a self-limited viral process related to the acute 
phase of Zika virus infection that usually resolves once the virus is cleared. Then, 
the vision returns to normal in the majority of the cases.
Non-purulent conjunctivitis is the most common non-congenital and self-lim-
ited ocular manifestation of Zika virus infection [101]. The adults that course with 
chorioretinal lesions, like immunocompromised patients that are in higher risk for 
presenting these fundus alterations, usually evolve as acute-onset and self-resolving 
lesions, with scaring and posterior improvement of visual acuity. Then this finding 
of Zika virus chorioretinitis may be a clear representation of the active phase of 
infection in a significant context of viremia. In the case of diagnosis of unilateral 
acute maculopathy related to Zika virus infection, the patient can be carefully 
monitored because there is usually visual function recovery, with improvement in 
the pigment epithelial and outer retinal architecture on optical coherence tomogra-
phy after the acute illness [52].
There has been described many non-congenital ocular complications related 
to arboviral infection, including epiescleritis, keratitis, uveitis, vitritis, macular 
atrophy, retinal vascular occlusion, optic neuritis and macular edema, with no 
specific or pathognomonic ocular lesion for Zika virus infection. Most patients 
recover completely, but there is always a small percentage of patients that evolve 
with permanent damage and subsequently can lead to long-life visual impairment 
[65]. Uveitis can be identified in adults during active Zika virus infection and has 
a benign prognosis. It is considered the principal difference between the ocular 
manifestations seen in acquired Zika infection and those observed in congenital 
Zika virus syndrome, because uveitis has been only reported in the acquired cases 
during viremia. Most cases evolve to complete regression and recovery of visual 
acuity after the viremia decreases and the use of topical treatment with steroids, 
cycloplegic and ocular hypertension drops [12].
10. Conclusion
Ocular involvement by ZIKV is related to the ability to break the blood-retinal 
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Among the affected infants, the most common ophthalmologic manifestations 
include optic nerve hypoplasia, increased cup-to-disk ratio, macular scarring and 
focal pigmentary retinal mottling, as well as anterior ocular findings and ocular 
motility alterations. The most sever ophthalmic manifestations occur when the 
infection takes place in the first trimester of pregnancy, exposure to the virus 
during pregnancy can cause devastating effects on the developing fetus, specially 
affecting the central nervous system. The associated pattern of birth defects is 
known as congenital Zika virus syndrome among adults, the manifestations are 
usually self-limited and in some cases require some kind of treatment. It is needed 
to focus the treatment according to the ophthalmic clinical context of each patient. 
Cases with CZS should be enrolled in an integral and multidisciplinary team for 
providing early-intervention services including cognitive and visual rehabilitation. 
Further studies are necessary to recognize the impact of ocular damage and neuro-
logical abnormalities and its long-term consequences in the affected children.
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